Article Text

This article has a correction. Please see:

other Versions

  • You are currently viewing an earlier version of this article (August 10, 2007).

PDF

Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveolar lavage fluid of HIV-infected patients
  1. Jim F Huggett
  1. University College London, United Kingdom
    1. Martin S Taylor
    1. University of Oxford, United Kingdom
      1. Gabrijela Kocjan
      1. University College London, United Kingdom
        1. Hannah E Evans
        1. University College London, United Kingdom
          1. Stephen Morris-Jones
          1. University Colege London Hospitals, United Kingdom
            1. Vanya Gant
            1. University College London Hospitals, United Kingdom
              1. Tanya Novak
              1. University College London, United Kingdom
                1. Anthony M Costello
                1. University College London, United Kingdom
                  1. Alimuddin Zumla
                  1. University College London, United Kingdom
                    1. Robert F Miller (rmiller{at}gum.ucl.ac.uk)
                    1. University College London, United Kingdom

                      Abstract

                      Background: Pneumocystis pneumonia (PCP) is conventionally diagnosed by identifying Pneumocystis jirovecii in lower respiratory tract samples using cytochemical stains. Molecular diagnosis of PCP is potentially more sensitive.

                      Objectives and methods: To use an extensively optimized real-time polymerase chain reaction (PCR) using primers designed to hybridise with the P. jirovecii heat-shock protein 70 (HSP70) gene to quantify P. jirovecii DNA in bronchoalveolar lavage (BAL) fluid from HIV-infected patients with and without PCP and to compare this assay with conventional PCR targeting the P. jirovecii mitochondrial large subunit rRNA gene sequence (mt LSU rRNA).

                      Results: Sixty-one patients had 62 episodes of PCP (defined by detection of P. jirovecii in BAL fluid by cytochemical stains and typical clinical presentation). Quantifiable HSP70 DNA was detected in 61/62; range ~13-18608 [median ~332] copies/reaction and detectable, below the limit of quantification (~5 copies/reaction, <LQ) in 1/62. Seventy-one other patients had 74 episodes with alternative diagnoses. Quantifiable HSP70 DNA was detectable in 6/74(8%) episodes; range ~6-590 [median ~14] copies/reaction and detectable but <LQ in 34/74(46%). Receiver-Operator Curve analysis (cut-off >10 copies/reaction) showed clinical sensitivity =98% (95% Confidence Interval (CI) =91-100%) and specificity =96% (95%CI =87-99%), for diagnosis of PCP. By contrast, clinical sensitivity and specificity of mt LSU rRNA PCR was 97% (95%CI =89-99%) and 68% (95 CI =56-78%), respectively.

                      Interpretation: The HSP70 real-time PCR assay detects P. jirovecii DNA in BAL fluid and may have a diagnostic application. Quantification of P. jirovecii DNA by real-time PCR may also discriminate between colonization with P. jirovecii and infection.

                      • PCP
                      • bronchoalveolar lavage
                      • diagnosis
                      • real-time PCR

                      Statistics from Altmetric.com

                      Request permissions

                      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

                      Linked Articles

                      • Correction
                        BMJ Publishing Group Ltd and British Thoracic Society